BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 31324254)

  • 1. Mdivi-1, a mitochondrial fission inhibitor, modulates T helper cells and suppresses the development of experimental autoimmune encephalomyelitis.
    Li YH; Xu F; Thome R; Guo MF; Sun ML; Song GB; Li RL; Chai Z; Ciric B; Rostami AM; Curtis M; Ma CG; Zhang GX
    J Neuroinflammation; 2019 Jul; 16(1):149. PubMed ID: 31324254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mdivi-1 Modulates Macrophage/Microglial Polarization in Mice with EAE via the Inhibition of the TLR2/4-GSK3β-NF-κB Inflammatory Signaling Axis.
    Liu X; Zhang X; Niu X; Zhang P; Wang Q; Xue X; Song G; Yu J; Xi G; Song L; Li Y; Ma C
    Mol Neurobiol; 2022 Jan; 59(1):1-16. PubMed ID: 34618332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mycobacterium bovis bacille Calmette-Guérin infection in the CNS suppresses experimental autoimmune encephalomyelitis and Th17 responses in an IFN-gamma-independent manner.
    Lee J; Reinke EK; Zozulya AL; Sandor M; Fabry Z
    J Immunol; 2008 Nov; 181(9):6201-12. PubMed ID: 18941210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peroxisome proliferator-activated receptor delta agonists inhibit T helper type 1 (Th1) and Th17 responses in experimental allergic encephalomyelitis.
    Kanakasabai S; Chearwae W; Walline CC; Iams W; Adams SM; Bright JJ
    Immunology; 2010 Aug; 130(4):572-88. PubMed ID: 20406305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infiltration of Th1 and Th17 cells and activation of microglia in the CNS during the course of experimental autoimmune encephalomyelitis.
    Murphy AC; Lalor SJ; Lynch MA; Mills KH
    Brain Behav Immun; 2010 May; 24(4):641-51. PubMed ID: 20138983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial division inhibitor 1 reduces dynamin-related protein 1 and mitochondrial fission activity.
    Manczak M; Kandimalla R; Yin X; Reddy PH
    Hum Mol Genet; 2019 Jan; 28(2):177-199. PubMed ID: 30239719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dietary naringenin supplementation attenuates experimental autoimmune encephalomyelitis by modulating autoimmune inflammatory responses in mice.
    Wang J; Qi Y; Niu X; Tang H; Meydani SN; Wu D
    J Nutr Biochem; 2018 Apr; 54():130-139. PubMed ID: 29331869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simvastatin ameliorates experimental autoimmune encephalomyelitis by inhibiting Th1/Th17 response and cellular infiltration.
    de Oliveira DM; de Oliveira EM; Ferrari Mde F; Semedo P; Hiyane MI; Cenedeze MA; Pacheco-Silva A; Câmara NO; Peron JP
    Inflammopharmacology; 2015 Dec; 23(6):343-54. PubMed ID: 26559850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cathepsin B inhibitor alleviates Th1, Th17, and Th22 transcription factor signaling dysregulation in experimental autoimmune encephalomyelitis.
    Ansari MA; Nadeem A; Alshammari MA; Attia SM; Bakheet SA; Khan MR; Albekairi TH; Alasmari AF; Alhosaini K; Alqahtani F; Al-Mazroua HA; Ahmad SF
    Exp Neurol; 2022 May; 351():113997. PubMed ID: 35122866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bee Venom Acupuncture Alleviates Experimental Autoimmune Encephalomyelitis by Upregulating Regulatory T Cells and Suppressing Th1 and Th17 Responses.
    Lee MJ; Jang M; Choi J; Lee G; Min HJ; Chung WS; Kim JI; Jee Y; Chae Y; Kim SH; Lee SJ; Cho IH
    Mol Neurobiol; 2016 Apr; 53(3):1419-1445. PubMed ID: 25579380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The flavonoid kurarinone inhibits clinical progression of EAE through inhibiting Th1 and Th17 cell differentiation and proliferation.
    Xie L; Gong W; Chen J; Xie HW; Wang M; Yin XP; Wu W
    Int Immunopharmacol; 2018 Sep; 62():227-236. PubMed ID: 30031314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amlexanox attenuates experimental autoimmune encephalomyelitis by inhibiting dendritic cell maturation and reprogramming effector and regulatory T cell responses.
    Quan MY; Song XJ; Liu HJ; Deng XH; Hou HQ; Chen LP; Ma TZ; Han X; He XX; Jia Z; Guo L
    J Neuroinflammation; 2019 Mar; 16(1):52. PubMed ID: 30823934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Korean Red Ginseng and Ginsenoside-Rb1/-Rg1 Alleviate Experimental Autoimmune Encephalomyelitis by Suppressing Th1 and Th17 Cells and Upregulating Regulatory T Cells.
    Lee MJ; Jang M; Choi J; Chang BS; Kim DY; Kim SH; Kwak YS; Oh S; Lee JH; Chang BJ; Nah SY; Cho IH
    Mol Neurobiol; 2016 Apr; 53(3):1977-2002. PubMed ID: 25846819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention and treatment of experimental autoimmune encephalomyelitis induced mice with 1, 25-dihydroxyvitamin D
    Haghmorad D; Yazdanpanah E; Jadid Tavaf M; Zargarani S; Soltanmohammadi A; Mahmoudi MB; Mahmoudi M
    Neurol Res; 2019 Oct; 41(10):943-957. PubMed ID: 31402771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. To mdivi-1 or not to mdivi-1: Is that the question?
    Smith G; Gallo G
    Dev Neurobiol; 2017 Nov; 77(11):1260-1268. PubMed ID: 28842943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasmacytoid DC promote priming of autoimmune Th17 cells and EAE.
    Isaksson M; Ardesjö B; Rönnblom L; Kämpe O; Lassmann H; Eloranta ML; Lobell A
    Eur J Immunol; 2009 Oct; 39(10):2925-35. PubMed ID: 19637225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opioid growth factor and low-dose naltrexone impair central nervous system infiltration by CD4 + T lymphocytes in established experimental autoimmune encephalomyelitis, a model of multiple sclerosis.
    Hammer LA; Waldner H; Zagon IS; McLaughlin PJ
    Exp Biol Med (Maywood); 2016 Jan; 241(1):71-8. PubMed ID: 26202376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppressive effect of IL-27 on encephalitogenic Th17 cells and the effector phase of experimental autoimmune encephalomyelitis.
    Fitzgerald DC; Ciric B; Touil T; Harle H; Grammatikopolou J; Das Sarma J; Gran B; Zhang GX; Rostami A
    J Immunol; 2007 Sep; 179(5):3268-75. PubMed ID: 17709543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decoy receptor 3 ameliorates experimental autoimmune encephalomyelitis by directly counteracting local inflammation and downregulating Th17 cells.
    Chen SJ; Wang YL; Kao JH; Wu SF; Lo WT; Wu CC; Tao PL; Wang CC; Chang DM; Sytwu HK
    Mol Immunol; 2009 Dec; 47(2-3):567-74. PubMed ID: 19819554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-7/IL-7 Receptor Signaling Differentially Affects Effector CD4+ T Cell Subsets Involved in Experimental Autoimmune Encephalomyelitis.
    Arbelaez CA; Glatigny S; Duhen R; Eberl G; Oukka M; Bettelli E
    J Immunol; 2015 Sep; 195(5):1974-83. PubMed ID: 26223651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.